Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Human Microbiome Market, by Product
1.4.2 Global Human Microbiome Market, by Disease Type
1.4.3 Global Human Microbiome Market, by Technology
1.4.4 Global Human Microbiome Market, by Application
1.4.5 Global Human Microbiome Market, by Type
1.4.6 Global Human Microbiome Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Global Human Microbiome Market by Product
3.1 Global Drugs Market by Region
3.2 Global Diagnostic Tests Market by Region
3.3 Global Probiotics Market by Region
3.4 Global Prebiotics Market by Region
3.5 Global Others Market by Region
Chapter 4. Global Human Microbiome Market by Disease Type
4.1 Global Infectious Diseases Market by Region
4.2 Global Endocrine & Metabolic Disorders Market by Region
4.3 Global Gastrointestinal Diseases Market by Region
4.4 Global Cancer Market by Region
4.5 Global Others Market by Region
Chapter 5. Global Human Microbiome Market by Technology
5.1 Global Genomics Market by Region
5.2 Global Proteomics Market by Region
5.3 Global Metabolomics Market by Region
Chapter 6. Global Human Microbiome Market by Application
6.1 Global Therapeutics Market by Region
6.2 Global Diagnostics Market by Region
Chapter 7. Global Human Microbiome Market by Type
7.1 Global Microbiome Consortia Transplantation (FMT) Market by Region
7.2 Global Peptide Market by Region
7.3 Global Live Biotherapeutic Product Market by Region
7.4 Global Others Market by Region
Chapter 8. Global Human Microbiome Market by Region
8.1 North America Human Microbiome Market
8.1.1 North America Human Microbiome Market by Product
8.1.1.1 North America Drugs Market by Country
8.1.1.2 North America Diagnostic Tests Market by Country
8.1.1.3 North America Probiotics Market by Country
8.1.1.4 North America Prebiotics Market by Country
8.1.1.5 North America Others Market by Country
8.1.2 North America Human Microbiome Market by Disease Type
8.1.2.1 North America Infectious Diseases Market by Country
8.1.2.2 North America Endocrine & Metabolic Disorders Market by Country
8.1.2.3 North America Gastrointestinal Diseases Market by Country
8.1.2.4 North America Cancer Market by Country
8.1.2.5 North America Others Market by Country
8.1.3 North America Human Microbiome Market by Technology
8.1.3.1 North America Genomics Market by Country
8.1.3.2 North America Proteomics Market by Country
8.1.3.3 North America Metabolomics Market by Country
8.1.4 North America Human Microbiome Market by Application
8.1.4.1 North America Therapeutics Market by Country
8.1.4.2 North America Diagnostics Market by Country
8.1.5 North America Human Microbiome Market by Type
8.1.5.1 North America Microbiome Consortia Transplantation (FMT) Market by Country
8.1.5.2 North America Peptide Market by Country
8.1.5.3 North America Live Biotherapeutic Product Market by Country
8.1.5.4 North America Others Market by Country
8.1.6 North America Human Microbiome Market by Country
8.1.6.1 US Human Microbiome Market
8.1.6.1.1 US Human Microbiome Market by Product
8.1.6.1.2 US Human Microbiome Market by Disease Type
8.1.6.1.3 US Human Microbiome Market by Technology
8.1.6.1.4 US Human Microbiome Market by Application
8.1.6.1.5 US Human Microbiome Market by Type
8.1.6.2 Canada Human Microbiome Market
8.1.6.2.1 Canada Human Microbiome Market by Product
8.1.6.2.2 Canada Human Microbiome Market by Disease Type
8.1.6.2.3 Canada Human Microbiome Market by Technology
8.1.6.2.4 Canada Human Microbiome Market by Application
8.1.6.2.5 Canada Human Microbiome Market by Type
8.1.6.3 Mexico Human Microbiome Market
8.1.6.3.1 Mexico Human Microbiome Market by Product
8.1.6.3.2 Mexico Human Microbiome Market by Disease Type
8.1.6.3.3 Mexico Human Microbiome Market by Technology
8.1.6.3.4 Mexico Human Microbiome Market by Application
8.1.6.3.5 Mexico Human Microbiome Market by Type
8.1.6.4 Rest of North America Human Microbiome Market
8.1.6.4.1 Rest of North America Human Microbiome Market by Product
8.1.6.4.2 Rest of North America Human Microbiome Market by Disease Type
8.1.6.4.3 Rest of North America Human Microbiome Market by Technology
8.1.6.4.4 Rest of North America Human Microbiome Market by Application
8.1.6.4.5 Rest of North America Human Microbiome Market by Type
8.2 Europe Human Microbiome Market
8.2.1 Europe Human Microbiome Market by Product
8.2.1.1 Europe Drugs Market by Country
8.2.1.2 Europe Diagnostic Tests Market by Country
8.2.1.3 Europe Probiotics Market by Country
8.2.1.4 Europe Prebiotics Market by Country
8.2.1.5 Europe Others Market by Country
8.2.2 Europe Human Microbiome Market by Disease Type
8.2.2.1 Europe Infectious Diseases Market by Country
8.2.2.2 Europe Endocrine & Metabolic Disorders Market by Country
8.2.2.3 Europe Gastrointestinal Diseases Market by Country
8.2.2.4 Europe Cancer Market by Country
8.2.2.5 Europe Others Market by Country
8.2.3 Europe Human Microbiome Market by Technology
8.2.3.1 Europe Genomics Market by Country
8.2.3.2 Europe Proteomics Market by Country
8.2.3.3 Europe Metabolomics Market by Country
8.2.4 Europe Human Microbiome Market by Application
8.2.4.1 Europe Therapeutics Market by Country
8.2.4.2 Europe Diagnostics Market by Country
8.2.5 Europe Human Microbiome Market by Type
8.2.5.1 Europe Microbiome Consortia Transplantation (FMT) Market by Country
8.2.5.2 Europe Peptide Market by Country
8.2.5.3 Europe Live Biotherapeutic Product Market by Country
8.2.5.4 Europe Others Market by Country
8.2.6 Europe Human Microbiome Market by Country
8.2.6.1 Germany Human Microbiome Market
8.2.6.1.1 Germany Human Microbiome Market by Product
8.2.6.1.2 Germany Human Microbiome Market by Disease Type
8.2.6.1.3 Germany Human Microbiome Market by Technology
8.2.6.1.4 Germany Human Microbiome Market by Application
8.2.6.1.5 Germany Human Microbiome Market by Type
8.2.6.2 UK Human Microbiome Market
8.2.6.2.1 UK Human Microbiome Market by Product
8.2.6.2.2 UK Human Microbiome Market by Disease Type
8.2.6.2.3 UK Human Microbiome Market by Technology
8.2.6.2.4 UK Human Microbiome Market by Application
8.2.6.2.5 UK Human Microbiome Market by Type
8.2.6.3 France Human Microbiome Market
8.2.6.3.1 France Human Microbiome Market by Product
8.2.6.3.2 France Human Microbiome Market by Disease Type
8.2.6.3.3 France Human Microbiome Market by Technology
8.2.6.3.4 France Human Microbiome Market by Application
8.2.6.3.5 France Human Microbiome Market by Type
8.2.6.4 Russia Human Microbiome Market
8.2.6.4.1 Russia Human Microbiome Market by Product
8.2.6.4.2 Russia Human Microbiome Market by Disease Type
8.2.6.4.3 Russia Human Microbiome Market by Technology
8.2.6.4.4 Russia Human Microbiome Market by Application
8.2.6.4.5 Russia Human Microbiome Market by Type
8.2.6.5 Spain Human Microbiome Market
8.2.6.5.1 Spain Human Microbiome Market by Product
8.2.6.5.2 Spain Human Microbiome Market by Disease Type
8.2.6.5.3 Spain Human Microbiome Market by Technology
8.2.6.5.4 Spain Human Microbiome Market by Application
8.2.6.5.5 Spain Human Microbiome Market by Type
8.2.6.6 Italy Human Microbiome Market
8.2.6.6.1 Italy Human Microbiome Market by Product
8.2.6.6.2 Italy Human Microbiome Market by Disease Type
8.2.6.6.3 Italy Human Microbiome Market by Technology
8.2.6.6.4 Italy Human Microbiome Market by Application
8.2.6.6.5 Italy Human Microbiome Market by Type
8.2.6.7 Rest of Europe Human Microbiome Market
8.2.6.7.1 Rest of Europe Human Microbiome Market by Product
8.2.6.7.2 Rest of Europe Human Microbiome Market by Disease Type
8.2.6.7.3 Rest of Europe Human Microbiome Market by Technology
8.2.6.7.4 Rest of Europe Human Microbiome Market by Application
8.2.6.7.5 Rest of Europe Human Microbiome Market by Type
8.3 Asia Pacific Human Microbiome Market
8.3.1 Asia Pacific Human Microbiome Market by Product
8.3.1.1 Asia Pacific Drugs Market by Country
8.3.1.2 Asia Pacific Diagnostic Tests Market by Country
8.3.1.3 Asia Pacific Probiotics Market by Country
8.3.1.4 Asia Pacific Prebiotics Market by Country
8.3.1.5 Asia Pacific Others Market by Country
8.3.2 Asia Pacific Human Microbiome Market by Disease Type
8.3.2.1 Asia Pacific Infectious Diseases Market by Country
8.3.2.2 Asia Pacific Endocrine & Metabolic Disorders Market by Country
8.3.2.3 Asia Pacific Gastrointestinal Diseases Market by Country
8.3.2.4 Asia Pacific Cancer Market by Country
8.3.2.5 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Human Microbiome Market by Technology
8.3.3.1 Asia Pacific Genomics Market by Country
8.3.3.2 Asia Pacific Proteomics Market by Country
8.3.3.3 Asia Pacific Metabolomics Market by Country
8.3.4 Asia Pacific Human Microbiome Market by Application
8.3.4.1 Asia Pacific Therapeutics Market by Country
8.3.4.2 Asia Pacific Diagnostics Market by Country
8.3.5 Asia Pacific Human Microbiome Market by Type
8.3.5.1 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country
8.3.5.2 Asia Pacific Peptide Market by Country
8.3.5.3 Asia Pacific Live Biotherapeutic Product Market by Country
8.3.5.4 Asia Pacific Others Market by Country
8.3.6 Asia Pacific Human Microbiome Market by Country
8.3.6.1 China Human Microbiome Market
8.3.6.1.1 China Human Microbiome Market by Product
8.3.6.1.2 China Human Microbiome Market by Disease Type
8.3.6.1.3 China Human Microbiome Market by Technology
8.3.6.1.4 China Human Microbiome Market by Application
8.3.6.1.5 China Human Microbiome Market by Type
8.3.6.2 Japan Human Microbiome Market
8.3.6.2.1 Japan Human Microbiome Market by Product
8.3.6.2.2 Japan Human Microbiome Market by Disease Type
8.3.6.2.3 Japan Human Microbiome Market by Technology
8.3.6.2.4 Japan Human Microbiome Market by Application
8.3.6.2.5 Japan Human Microbiome Market by Type
8.3.6.3 India Human Microbiome Market
8.3.6.3.1 India Human Microbiome Market by Product
8.3.6.3.2 India Human Microbiome Market by Disease Type
8.3.6.3.3 India Human Microbiome Market by Technology
8.3.6.3.4 India Human Microbiome Market by Application
8.3.6.3.5 India Human Microbiome Market by Type
8.3.6.4 South Korea Human Microbiome Market
8.3.6.4.1 South Korea Human Microbiome Market by Product
8.3.6.4.2 South Korea Human Microbiome Market by Disease Type
8.3.6.4.3 South Korea Human Microbiome Market by Technology
8.3.6.4.4 South Korea Human Microbiome Market by Application
8.3.6.4.5 South Korea Human Microbiome Market by Type
8.3.6.5 Singapore Human Microbiome Market
8.3.6.5.1 Singapore Human Microbiome Market by Product
8.3.6.5.2 Singapore Human Microbiome Market by Disease Type
8.3.6.5.3 Singapore Human Microbiome Market by Technology
8.3.6.5.4 Singapore Human Microbiome Market by Application
8.3.6.5.5 Singapore Human Microbiome Market by Type
8.3.6.6 Malaysia Human Microbiome Market
8.3.6.6.1 Malaysia Human Microbiome Market by Product
8.3.6.6.2 Malaysia Human Microbiome Market by Disease Type
8.3.6.6.3 Malaysia Human Microbiome Market by Technology
8.3.6.6.4 Malaysia Human Microbiome Market by Application
8.3.6.6.5 Malaysia Human Microbiome Market by Type
8.3.6.7 Rest of Asia Pacific Human Microbiome Market
8.3.6.7.1 Rest of Asia Pacific Human Microbiome Market by Product
8.3.6.7.2 Rest of Asia Pacific Human Microbiome Market by Disease Type
8.3.6.7.3 Rest of Asia Pacific Human Microbiome Market by Technology
8.3.6.7.4 Rest of Asia Pacific Human Microbiome Market by Application
8.3.6.7.5 Rest of Asia Pacific Human Microbiome Market by Type
8.4 LAMEA Human Microbiome Market
8.4.1 LAMEA Human Microbiome Market by Product
8.4.1.1 LAMEA Drugs Market by Country
8.4.1.2 LAMEA Diagnostic Tests Market by Country
8.4.1.3 LAMEA Probiotics Market by Country
8.4.1.4 LAMEA Prebiotics Market by Country
8.4.1.5 LAMEA Others Market by Country
8.4.2 LAMEA Human Microbiome Market by Disease Type
8.4.2.1 LAMEA Infectious Diseases Market by Country
8.4.2.2 LAMEA Endocrine & Metabolic Disorders Market by Country
8.4.2.3 LAMEA Gastrointestinal Diseases Market by Country
8.4.2.4 LAMEA Cancer Market by Country
8.4.2.5 LAMEA Others Market by Country
8.4.3 LAMEA Human Microbiome Market by Technology
8.4.3.1 LAMEA Genomics Market by Country
8.4.3.2 LAMEA Proteomics Market by Country
8.4.3.3 LAMEA Metabolomics Market by Country
8.4.4 LAMEA Human Microbiome Market by Application
8.4.4.1 LAMEA Therapeutics Market by Country
8.4.4.2 LAMEA Diagnostics Market by Country
8.4.5 LAMEA Human Microbiome Market by Type
8.4.5.1 LAMEA Microbiome Consortia Transplantation (FMT) Market by Country
8.4.5.2 LAMEA Peptide Market by Country
8.4.5.3 LAMEA Live Biotherapeutic Product Market by Country
8.4.5.4 LAMEA Others Market by Country
8.4.6 LAMEA Human Microbiome Market by Country
8.4.6.1 Brazil Human Microbiome Market
8.4.6.1.1 Brazil Human Microbiome Market by Product
8.4.6.1.2 Brazil Human Microbiome Market by Disease Type
8.4.6.1.3 Brazil Human Microbiome Market by Technology
8.4.6.1.4 Brazil Human Microbiome Market by Application
8.4.6.1.5 Brazil Human Microbiome Market by Type
8.4.6.2 Argentina Human Microbiome Market
8.4.6.2.1 Argentina Human Microbiome Market by Product
8.4.6.2.2 Argentina Human Microbiome Market by Disease Type
8.4.6.2.3 Argentina Human Microbiome Market by Technology
8.4.6.2.4 Argentina Human Microbiome Market by Application
8.4.6.2.5 Argentina Human Microbiome Market by Type
8.4.6.3 UAE Human Microbiome Market
8.4.6.3.1 UAE Human Microbiome Market by Product
8.4.6.3.2 UAE Human Microbiome Market by Disease Type
8.4.6.3.3 UAE Human Microbiome Market by Technology
8.4.6.3.4 UAE Human Microbiome Market by Application
8.4.6.3.5 UAE Human Microbiome Market by Type
8.4.6.4 Saudi Arabia Human Microbiome Market
8.4.6.4.1 Saudi Arabia Human Microbiome Market by Product
8.4.6.4.2 Saudi Arabia Human Microbiome Market by Disease Type
8.4.6.4.3 Saudi Arabia Human Microbiome Market by Technology
8.4.6.4.4 Saudi Arabia Human Microbiome Market by Application
8.4.6.4.5 Saudi Arabia Human Microbiome Market by Type
8.4.6.5 South Africa Human Microbiome Market
8.4.6.5.1 South Africa Human Microbiome Market by Product
8.4.6.5.2 South Africa Human Microbiome Market by Disease Type
8.4.6.5.3 South Africa Human Microbiome Market by Technology
8.4.6.5.4 South Africa Human Microbiome Market by Application
8.4.6.5.5 South Africa Human Microbiome Market by Type
8.4.6.6 Nigeria Human Microbiome Market
8.4.6.6.1 Nigeria Human Microbiome Market by Product
8.4.6.6.2 Nigeria Human Microbiome Market by Disease Type
8.4.6.6.3 Nigeria Human Microbiome Market by Technology
8.4.6.6.4 Nigeria Human Microbiome Market by Application
8.4.6.6.5 Nigeria Human Microbiome Market by Type
8.4.6.7 Rest of LAMEA Human Microbiome Market
8.4.6.7.1 Rest of LAMEA Human Microbiome Market by Product
8.4.6.7.2 Rest of LAMEA Human Microbiome Market by Disease Type
8.4.6.7.3 Rest of LAMEA Human Microbiome Market by Technology
8.4.6.7.4 Rest of LAMEA Human Microbiome Market by Application
8.4.6.7.5 Rest of LAMEA Human Microbiome Market by Type
Chapter 9. Company Profiles
9.1 Ferring Holdings SA
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research and Development Expense
9.1.5 Recent Strategies and Developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
9.2.1 Company Overview
9.2.2 Recent Strategies and Developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Research & Development Expense
9.3.4 Recent Strategies and Developments:
9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent Strategies and Developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
9.5.1 Company Overview
9.6 Synlogic, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense
Unique Offerings 
